Michael Balmuth, MBA
Michael Balmuth, MBA, leads Edison Ventures' industry sector practice in healthcare information technology nd heads the firm’s New England team based in Boston. He has been lead investor in software and technology-enabled services companies in healthcare IT, interactive marketing, financial technology and other enterprise applications. Michael has served on the board of numerous Edison investments, including: Andera, Blue Cod Technologies, CambridgeSoft (acquired by Perkin Elmer), DiagnosisOne, Octagon Research, PlumChoice, RewardsNow and VFA. In 2012, he successfully guided two healthcare IT investments toward M&A exits – Octagon Research’s acquisition by Accenture and DiagnosisOne’s acquisition by Alere. Michael has more than 25 years of technology industry experience as a venture capitalist, investment banker and software executive. Before Edison, during the past 15 years in the Boston area, he served as Managing Partner of Mainspring Capital and General Partner at Summit Partners. At Summit, he led the East Coast office of Summit Venture Capital Fund as a founding partner. Previously, Michael worked in technology investment banking with Broadview International. His early career at IBM Corporation spanned sales, marketing, corporate development and systems engineering. Michael has served as a Director of numerous public and private companies. Prior investments, all of which exited at gains through an IPO or strategic M&A include: Infor; Unica; OPNET; MCK Communications; Future Three; InstallShield; Microbank; PowerSmart; Staples.com; TrelliSoft. Michael earned a BA degree in Engineering Sciences from Dartmouth College and an MBA from Harvard Business School.